"Ending AIDS Apartheid"

var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); ion" CONTENT="The manner in which experimental drug trials for people with AIDS are conducted may be why they are attracting so few patients in New York City. Although the system requires that teaching hospitals team up with city hospitals on drug trials, few poor and minority patients ever make it into a study. Part of the probl"> "Ending AIDS Apartheid" < > // var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); > < > // var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); >

Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

"Ending AIDS Apartheid"

Village Voice (12/27/88) Vol. 33, No. 52, P. 14
Goldstein, Richard

Abstract: The manner in which experimental drug trials for people with AIDS are conducted may be why they are attracting so few patients in New York City. Although the system requires that teaching hospitals team up with city hospitals on drug trials, few poor and minority patients ever make it into a study. Part of the problem is caused by inefficiency at the city's Health and Hospitals Corporation (HHC) and at the hospitals themselves. New York University Medical Center recently averted a large ACT UP demonstration by ending a logjam that had prevented all but a few patients from Bellevue, the city hospital it is paired with, from taking part in NYU studies. Although an NYU spokesman said National Institute of Allergy and Infectious Diseases protocols for prospective studies are immediately passed on to HHC and Bellevue, it took ACT UP pressure to produce seven protocols that had fallen through the cracks at either the city agency or the hospital. HHC says it has reduced the time necessary to process trials from 150 to 50 days, but it processed three protocols in two days under ACT UP pressure.
881227
AD880431

Copyright © 1988 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

< type="text/java "> var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); > < type="text/java " src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); >

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .